Fluorouracil (Taro Pharmaceutical Industries Ltd.)
Welcome to the PulseAid listing for the Fluorouracil drug offered from Taro Pharmaceutical Industries Ltd.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Taro Pharmaceutical Industries Ltd. |
NON-PROPRIETARY NAME: | Fluorouracil |
SUBSTANCE NAME: | FLUOROURACIL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | TOPICAL |
DOSAGE FORM: | CREAM |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2010-03-05 |
END MARKETING DATE: | 0000-00-00 |
Fluorouracil HUMAN PRESCRIPTION DRUG Details:
Item Description | Fluorouracil from Taro Pharmaceutical Industries Ltd. |
LABELER NAME: | Taro Pharmaceutical Industries Ltd. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/g) |
START MARKETING DATE: | 2010-03-05 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 52549-4118_96620eda-0669-4a7b-96ac-40206379d659 |
PRODUCT NDC: | 52549-4118 |
APPLICATION NUMBER: | ANDA090368 |
Other FLUOROURACIL Pharmaceutical Manufacturers / Labelers: